Drugs.com - FDA MedWatch Alerts

B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers Due to the Potential for Particulate Matter and Leakage

Audience: Healthcare Provider, Pharmacy, Consumer BETHLEHEM, PA - August 8, 2024 – B. Braun Medical Inc. (B. Braun), is voluntarily recalling two (2) lots of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 containers within the United...

Feb 9, 2025 - 21:45
 0
B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers Due to the Potential for Particulate Matter and Leakage
Audience: Healthcare Provider, Pharmacy, Consumer BETHLEHEM, PA - August 8, 2024 – B. Braun Medical Inc. (B. Braun), is voluntarily recalling two (2) lots of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 containers within the United...
Read More

Tags:

Previous Article

FDA Warns Consumers to Not Purchase or Use Unapproved Inhalant Products Marketed...

Next Article

Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium in 0.9% S...

Related Posts

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid ...

Feb 9, 2025  0

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

Feb 9, 2025  0

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Gilead Issues Voluntary Nationwide Recall of One Lot of...

Feb 9, 2025  0